title: TDP-43-positive white matter pathology in frontotemporal lobar degeneration with ubiquitin-positive inclusions.
abstract: TDP-43 was recently identified as the major disease protein in neuronal inclusions in frontotemporal lobar degeneration with ubiquitin-positive inclusions (FTLD-U). TDP-43 is not only linked to disease mechanisms in FTLD-U, but it is also the most robust marker for the specific detection of neuronal inclusions in FTLD-U. In this study, we describe additional TDP-43 pathology in the white matter as a characteristic feature in a series of 38 FTLD-U cases including 3 cases with mutations in the progranulin gene. White matter pathology was most abundant in frontal and temporal lobes, but it was also detectable in brainstem and spinal cord. Based on morphology and double-labeling experiments, white matter cells with TDP-43-positive inclusions most likely represent oligodendrocytes. Biochemically, hyperphosphorylated and truncated TDP-43 was detectable in insoluble brain extracts from affected white matter regions in FTLD-U, similar to the biochemical signature observed in FTLD-U gray matter. Taken together, these results expand the spectrum of TDP-43 pathology in FTLD-U, suggesting that white matter pathology might contribute to the neurodegenerative process and clinical symptoms in FTLD-U.
authors.affiliation: Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. Manuela.Neumann@med.uni-muenchen.de
authors.forename: Manuela
authors.initials: M
authors.lastname: Neumann
authors.forename: Linda K
authors.initials: LK
authors.lastname: Kwong
authors.forename: Adam C
authors.initials: AC
authors.lastname: Truax
authors.forename: Ben
authors.initials: B
authors.lastname: Vanmassenhove
authors.forename: Hans A
authors.initials: HA
authors.lastname: Kretzschmar
authors.forename: Vivianna M
authors.initials: VM
authors.lastname: Van Deerlin
authors.forename: Chrisopher M
authors.initials: CM
authors.lastname: Clark
authors.forename: Murray
authors.initials: M
authors.lastname: Grossman
authors.forename: Bruce L
authors.initials: BL
authors.lastname: Miller
authors.forename: John Q
authors.initials: JQ
authors.lastname: Trojanowski
authors.forename: Virginia M-Y
authors.initials: VM
authors.lastname: Lee
mesh_terms: D000328:Adult; D000368:Aged; D015703:Antigens, CD / Q000378:metabolism; D015214:Antigens, Differentiation, Myelomonocytic / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism*; D003704:Dementia / Q000378:metabolism* / Q000473:pathology*; D005260:Female; D005625:Frontal Lobe / Q000378:metabolism / Q000473:pathology; D005904:Glial Fibrillary Acidic Protein / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D002479:Inclusion Bodies / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D013702:Temporal Lobe / Q000378:metabolism / Q000473:pathology; D025801:Ubiquitin / Q000378:metabolism*; D000097382:CD68 Molecule
chemical_list: D015703:Antigens, CD; D015214:Antigens, Differentiation, Myelomonocytic; D004268:DNA-Binding Proteins; D005904:Glial Fibrillary Acidic Protein; D025801:Ubiquitin; C067980:CD68 antigen, human; D000097382:CD68 Molecule